Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 250 movers: Genus slumps; Indivior rallies
(Sharecast News) - FTSE 250 (MCX) 21,115.29 -0.46% Animal genetics firm Genus was under the cosh after it said profits this year would be lower than expected due to ongoing market challenges in China and Brazil.
The company, which uses gene-editing and genomic science to improve breeding for lifestock farmers and food producers, said its PIC or pigs division performed in line with expectations over the fourth quarter ended 30 June, though the porcine market in China "continues to be challenging".
Meanwhile, in ABS, which comprises dairy and beef cattle operations, the company experienced lower volumes in the second half compared with last year, as weak demand persisted in several countries, most notably China and Brazil, which impacted profits.
Nevertheless, Genus still guided to a full-year adjusted pre-tax profit of between £58m and £61m, in line with market expectations. "This shortfall in ABS adjusted operating profits was offset by the realisation of early savings as a result of actions taken following the R&D strategic review completed in February 2024," the company said.
Genus said it expects a "significant improvement" in ABS's profit position in the current financial year. However, both ABS volumes and the group's overall adjusted operating profit are estimated to be lower than previously estimated in the year ending June 2025 "due to the continuation of weak demand in several countries, including China and Brazil".
Indivior rallied after a profit warning last week along with signalling a slowdown in sales of its top-selling opioid addiction treatment, and said it would discontinue sales of its schizophrenia drug Perseris. The stock is still well below the 1181p level before the announcement.
Market Movers
FTSE 250 - Risers
Indivior (INDV) 816.00p 4.21% Diversified Energy Company (DEC) 1,295.00p 3.77% Pennon Group (PNN) 640.50p 3.22% Abrdn (ABDN) 166.75p 2.46% Ithaca Energy (ITH) 127.40p 2.08% Close Brothers Group (CBG) 526.50p 1.84% Elementis (ELM) 147.40p 1.80% PPHE Hotel Group Ltd (PPH) 1,425.00p 1.79% Domino's Pizza Group (DOM) 325.20p 1.50% Lancashire Holdings Limited (LRE) 623.00p 1.47%
FTSE 250 - Fallers
Genus (GNS) 1,712.00p -10.08% Allianz Technology Trust (ATT) 384.00p -4.60% Polar Capital Technology Trust (PCT) 3,265.00p -3.97% Plus500 Ltd (DI) (PLUS) 2,180.00p -3.96% Ibstock (IBST) 189.20p -3.57% Discoverie Group (DSCV) 734.00p -2.52% Marshalls (MSLH) 349.50p -2.37% Bridgepoint Group (Reg S) (BPT) 249.40p -2.35% BlackRock Greater Europe Inv Trust (BRGE) 618.00p -2.22% Pagegroup (PAGE) 414.60p -2.17%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
